Shedding Light on the Risks & Benefits of Medications

Search Results for: medical device error

Inside the FDA’s Quiet Move to Weaken Drug Approval Standards

The Food and Drug Administration (FDA) is preparing to reduce the default number of clinical trials it will require to approve new drugs, a shift…

Dec 17, 2025

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Sep 18, 2025

DONATE:

Help fund our fight for improved medication safety and transparency by supporting our independent journalism.

Give Now

Stay Informed. Sign up for our newsletters.

Independent, science-based journalism delivered directly to your inbox.

WEBINARS

Want to hear expert insights about medication safety and other care options? Watch all our past webinars and sign up for upcoming ones.

WATCH Now

Search Results for: medical device error

Inside the FDA’s Quiet Move to Weaken Drug Approval Standards

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

RECOMMENDED:

FDA Drug Recalls and Warnings: Serious Risks of Unapproved Botox Injectables

FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More

FDA Drug Recalls and Warnings: Blood Pressure Meds Tainted With Cancer-Causing Chemicals, Gabapentin Impurities and More

DONATE:

Stay Informed. Sign up for our newsletters.

WEBINARS

Follow Us On:

Download our App: